Sunshine Proposal Allows Lump Sum Reporting Of Research Payments To Institutions
Executive Summary
CMS-proposed rule would allow companies to report a single figure for research payments to institutions and attribute it to the principal investigator(s), although the agency will not include it when computing physicians’ total receipts from industry. The agency wants more details on what payments are for, calling on firms to break them down by category when more than one expense type is included in a single payment.
You may also be interested in...
Six Months Till Sunrise: CMS Allows Extra Time For Firms To Collect Physicians Payment Data
Drug makers get three more months to comply than the proposed rule offered; firms must send the data by March 31, 2014, to CMS, which plans to make the information available on a public website by Sept. 30, 2014.
HHS’ Holiday Gift To Industry: Delayed Collection Of Physician Payments Data
CMS postpones the deadline for drug makers to begin full implementation of the Sunshine Act until after it issues a final rule on how to collect the data. Current plans are to keep the March 31, 2013, deadline for companies to submit to HHS the data they do collect for 2012.
Physician Payments Sunshine Rule From CMS Expected By Year's End
Pharmaceutical companies will have a little more than a year to put together data to comply with CMS regulations for reporting payments made to physicians if the agency meets its current timeline for issuing the rules.